Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy
PHASE2
The purpose of this trial is to evaluate safety and to compare the efficacy...
Status
Completed
Location
Center for Clinical Trials - Association for Innovation and Biomedical Research on Light and Image
Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.
PHASE2
This study is a prospective, randomized, multicentre, open label study that...
Status
Completed
Location
Department of Ophthalmology, University Hospital, CHU Dijon